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ABSTRACT
Human IgE synthesis is largely dependent on the pro-
duction of interleukin (IL)-4 or IL-13 and the expression
of CD40 ligand. Such B cell help is not only provided
by CD4+ T cells, but also by CD8+ T cells, gd T cells,
mast cells, basophils and eosinophils. The IL-4 recep-
tor a chain (IL-4Ra ) expressed on B cells is shared by
the functional IL-4R and IL-13R and is a crucial com-
ponent required for signal transduction leading to
germline Ce transcription, which is a prerequisite for
IgE isotype switching. Interleukin-4 activates Janus
kinase (JAK)1, JAK3 and phosphatidylinositol 3-kinase
(PI3-K) and, subsequently, induces nuclear trans-
location of signal transducers and activators of
transcription (STAT)6 and nuclear factor (NF)-k B,
which interact at the level of the Ie promoter. The two
variants of the IL-4Ra , which have been identified in
association with atopy, are associated with enhanced
responsiveness to IL-4. Ligation of CD40 on B cells 
up-regulates IL-4- or IL-13-driven germline Ce
transcription and further induces deletional switch
recombination that results in IgE isotype switching,
mature Ce transcription and IgE synthesis. Signaling
pathways mediated by CD40 include activation of Lyn,
PI3-K, JAK3 and members of the mitogen-activated
protein kinase subfamily, multimerization of tumor
necrosis factor-a receptor-associated factor (TRAF)2,
TRAF3, TRAF5 and TRAF6 and translocation of NF-k B
and STAT3. In addition, Ku70/86, DNA-dependent
protein kinase and rad51/54 may be involved in
switch recombination. Taken together, activation of
kinases, induction of second messengers, nuclear
expression of transcription factors and localization of
DNA-binding proteins are integrated to produce the
terminal differentiation of a B cell into an IgE-secreting
plasma cell. Elucidation of the detailed mechanisms of
IgE isotype switching will contribute to the development
of potential new therapeutic procedures for the regula-
tion of the IgE response in atopic patients.
Key words: atopy, CD40 ligand, IgE, interleukin-4,
switch recombination.
INTRODUCTION
Immunoglobulin E plays a central role in the pathogene-
sis of allergic diseases, including asthma, rhinitis and
urticaria. The production of IgE is initiated by the inter-
action of B cells with T cells and is regulated by soluble
and cell surface molecules provided by activated T cells.
During the development of the IgE response, B cells can
differentiate into IgE-secreting plasma cells. This differen-
tiation process involves isotype switching, which allows
expression of IgE. Although a complete set of switch
recombination events is still unknown, considerable
progress has been made in the past decade in elucidat-
ing the class-specific mechanisms of IgE regulation. The
aim of the present article is to provide a current overview
of the cellular, biochemical and molecular events under-
lying human IgE synthesis.
CELL TYPES SUPPORTING IgE PRODUCTION BY
B CELLS
Mature B cells, which express IgM and IgD antigen
receptors, respond to protein antigens and T cell help by
undergoing proliferation, Ig class switching and plasma
cell differentiation. T cell help is mediated through cyto-
kines and cell surface molecules provided by activated
CD4+ T cells. Two cytokines, interleukin (IL)-4 and IL-13,
are functionally related and direct IgE synthesis in B cells.
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Cell interaction molecules important for the antibody
responses include CD40 on B cells and CD40 ligand
(CD40L, CD154) expressed on activated CD4+ T cells.1,2
Both the transmembrane form of tumor necrosis factor
(TNF)-a on activated CD4+ T cells and CD2 on T cells are
also involved in the productive T–B cell interactions that
are required for IgE synthesis.3,4 Nevertheless, CD40L
appears to be most important in providing a costimulatory
signal for B cell activation, because T cell-dependent B
cell responses, including IgE production, can be blocked
by soluble forms of CD40. Actually, engagement of CD40
leads to B cell proliferation and differentiation in the pres-
ence of certain cytokines, which supports the notion that
the CD40–CD40L interaction is central to the delivery of 
T cell help to B cells. The essential role of the
CD40–CD40L interaction in Ig class switching has been
shown in patients with X-linked hyper-IgM syndrome, who
have a reduction or loss of isotype switching due to defec-
tive CD40L expression.5 The CD40L is also expressed on
CD8+ T cells, gd T cells, mast cells, basophils and
eosinophils upon activation.6–10 Thus, these cells can
replace CD4+ T cells in delivering the contact-mediated
signal required for IgE synthesis.
In addition to CD40L, cytokines produced by several
cell types, including T cells, play an important regulatory
role in the immune response. CD4+ helper T (Th) cells are
classified into two distinct cytokine-secreting subsets, Th1
and Th2.11 T helper 2 cells, the counterparts of Th1 cells
(which secrete IL-2, interferon (IFN)-g and lymphotoxin),
produce IL-4, IL-5, IL-6, IL-10 and IL-13 and are associ-
ated with antibody and allergic responses. CD8+
cytotoxic T cells are also similarly divided into two
subsets, termed Tc1 and Tc2 cells.12 Cells in the Tc1
subset produce Th1-type cytokines, while Tc2 cells, which
have decreased cytolytic activity, secrete Th2-type
cytokines. Interestingly, CD40L is preferentially expressed
on Tc2 rather than Tc1 cells. Cytotoxic T cell 2-type CD8+
T cells have been described in patients with lepromatous
leprosy, acquired immune deficiency syndrome and
atopy.7,13–15 A recent study has shown that CD8+ T cells
with a Tc2 phenotype are also detectable in a patient with
an adenosine deaminase deficiency who has received
autologous T cell-directed gene therapy.16,17 Interleukin-
4 and/or IL-13 are secreted not only by Th2 cells, but
also by Th0 cells, Tc2 cells, mast cells, basophils and
eosinophils. Naïve CD4+ T cells and Th1 cells, although
lacking the ability to produce IL-4, secrete IL-13, thereby
contributing to IgE production by B cells.18 These findings
indicate that, like Th2 cells, other cell types also partici-
pate in a form of the immunological synapse by produc-
ing IL-4 or IL-13 and expressing CD40L. This is supported
by the observation that, in severe combined immuno-
deficiency mice reconstituted with peripheral blood
mononuclear cells from atopic patients, IL-4 production
and CD40L expression can be detected not only in CD4+
T cells but also in CD8+ T cells, gd T cells and high-
affinity IgE receptor (Fce RI)-bearing cells (probably
basophils).17 By itself, IgE has the capacity to enhance
expression of Fce RI on mast cells,19 to stabilize CD23 on
B cells20 and to facilitate cholinergic neurotransmission in
airways.21 Thus, exposure to monomeric IgE also con-
tributes to the pathogenesis of allergic diseases. In this
regard, Tc2 cells, gd T cells, mast cells, basophils and
eosinophils, in addition to allergen-specific CD4+ T cells,
may be important targets for achieving the down-
regulation of IgE synthesis by B cells (Fig. 1).
MOLECULAR EVENTS IN IgE ISOTYPE SWITCHING
In antibody responses, IgM+ IgD+ B cells undergo isotype
switching that results in the production of other Ig classes
(IgG, IgA or IgE). Isotype switching of the constant region of
the heavy chain (CH) allows a new CH gene to be tran-
scribed with the same variable gene, thus keeping the
antigen-binding specificity unchanged. The mechanisms
by which different isotypes are produced may be explained
by a model of alignment of two switch (S) region sequences
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Fig. 1 Cell types that support IgE production by B cells. After
appropriate stimulation, cytotoxic T cell (Tc)2 cells, gd T cells,
mast cells, basophils and eosinophils secrete interleukin (IL)-4
and/or IL-13 and express CD40L. Such cellular responses
provide help to adjacent B cells, resulting in the induction of IgE
production. This may also involve up-regulation of IgE synthesis
induced by allergen-specific T helper 2 (Th2) cells.
with the deletion of the intervening DNA region.22 The
S regions located upstream of each CH gene, except Cd ,
include Sm , Sg , Sa and Se (Fig. 2a). In addition, the
germline I exon is located upstream of the Sg , Sa or Se
region. The specificity of isotype switching from Cm to Cg ,
Ca or Ce is regulated by cytokines that direct switching by
altering the accessibility of CH genes and their S regions to
a common recombinase system.
In the course of the IgE response, B cells differentiate
into plasma cells or memory cells that produce IgE. This
differentiation process allows a single B cell to switch from
the production of IgM to IgE at the molecular level. As
shown in Fig. 2b, IgE isotype switching occurs by a DNA
rearrangement that is accompanied by the looping out and
deletion of the intervening DNA between the Sm and Se
regions.23,24 Thus, activation of transcription through the
Se region is an essential step in the IgE switching process.
Induction of IgE isotype switching is preceded by transcrip-
tion of Ce RNA, which initiates from the Ie promoter
containing an IL-4 response element. This promoter con-
tains binding sites for transcription factors, including
signal transducers and activators of transcription (STAT)6,
nuclear factor (NF)-k B and B cell-specific activator
protein.25–27 Nuclear expression of these transcription
factors results in transcription of the Ie exon, the Se region
and the Ce exons (Ce 1–Ce 4). The germline Ce transcript
is composed of the Ie and Ce exons, because the Se
region is spliced out. Transcripts of the Se region, but not
germline Ce transcripts, may play a role in Sm /Se switch
recombination through DNA complex formation.28 Both
IL-4 and IL-13 induce germline Ce transcription in
B cells, with the subsequent ability to induce IgE switching.
Although regulation of germline Ce transcription by cyto-
kines, such as IFN-g , TNF-a and transforming growth
factor-b , correlates well with levels of IgE production,
additional costimulatory molecules, including CD40L,
are required for the induction of IgE isotype switching.
CD40 ligation enhances IL-4- or IL-13-driven germline
Ce transcription and further induces the deletional switch
recombination that results in IgE switching. This DNA
switch recombination induces the substitution of the Cm
gene for the Ce gene and subsequently brings a specific
variable region adjacent to a rearranged Ce gene, allow-
ing mature Ce transcription and IgE synthesis. Therefore,
MECHANISMS OF IgE REGULATION 113
Fig. 2 Schematic diagram of the molecular events in IgE isotype switching. (a) Genes of CH isotypes and S regions in a B cell
expressing IgM and IgD. (b) DNA switch recombination that results in IgE isotype switching. See text for details.
both membrane and secreted forms of IgE are expressed
by the same cell at different stages of differentiation.
Although the transition from the membrane to the secreted
form of IgE involves alternative mRNA splicing, the extra-
cellular, transmembrane and cytoplasmic domains of IgE
regulate IgE secretion or IgE responses.29–31
INTERLEUKIN-4 SIGNAL TRANSDUCTION EVENTS
LEADING TO GERMLINE Ce TRANSCRIPTION
Both IL-4 and IL-13 contribute to the induction of
germline Ce transcription, the production of IgE and the
expression of CD23 by B cells. These overlapping effects
of IL-4 and IL-13 on B cell function are mediated by the
binding of cytokines to their specific receptors on B cells.
The functional IL-4 receptor (IL-4R) consists of at least two
components, the IL-4R a chain (IL-4Ra ) and the IL-2R g
chain, termed the common g chain (g c).32,33 Although the
g c is a shared element of the receptors for IL-2, IL-4, IL-7,
IL-9 and IL-15, the IL-4R a may be shared by IL-13R.
Several studies have demonstrated that an IL-13-binding
chain (IL-13Ra ) associates with the IL-4Ra 34,35 and that
B cells of X-linked severe combined immunodeficiency
patients with mutations in the g c gene are induced to
express germline Ce transcripts by IL-4 and IL-13 and
to produce IgE by costimulation with IL-4 or IL-13 and an
agonistic anti-CD40 monoclonal antibody (mAb).36,37
Thus, the IL-4Ra is a common component of the func-
tional IL-4R and IL-13R in B cells.
Many cytokine receptors, including IL-4Ra , g c and
IL-13R a , do not have any unique sequences for signal
transduction, such as protein tyrosine kinase (PTK) sites,
in their intracytoplasmic domain. However, cytokine bind-
ing induces tyrosine phosphorylation and activation of
members of the Janus kinase (JAK) family,38,39 indicating
that the intracellular portions of cytokine receptors func-
tion as binding sites for cytoplasmic JAK. Activated JAK
phosphorylate tyrosine residues in the cytoplasmic tails of
the oligomerized cytokine receptor, thereby resulting in
association with the Src-homology (SH) 2 domains of
members of the STAT family. The JAK further phos-
phorylate STAT proteins recruited to the phosphorylated
cytokine receptor. The receptor chains IL-4Ra , g c and
IL-13R a associate with JAK1, JAK3, and JAK2 and TYK2,
respectively. Interleukin-4 and IL-13 induce phosphory-
lation of JAK1, which, in turn, activates STAT6. When the
phosphorylated STAT6 forms a homodimer via the SH2
domain, this dimer is dissociated from the IL-4Ra ,
translocates to the nucleus and binds to the consensus
sequence in the Ie promoter. Thus, STAT6 is an important
transcription factor that regulates the expression of
various genes by IL-4 and IL-13. For example, transfec-
tion of decoy oligodeoxynucleotides containing STAT6
binding sites into a human B cell line, as well as pretreat-
ment with herbimycin A, a PTK inhibitor, leads to a
marked decrease in germline Ce transcription induced by
IL-4.40,41 The essential role of STAT6 in IgE synthesis has
been shown in STAT6-deficient mice.42,43
Nuclear factor-k B, known to play a broad role in gene
regulation, is also activated by IL-4. Inactive NF-k B, which
is present in a non-DNA binding form in the cytoplasm, is
a heterotrimer composed of three subunits. Phosphory-
lation and dissociation of the Ik B subunit results in the
translocation of the active heterodimer (p50/p65 or
p50/rel) to the nucleus, in which active NF-k B binds to its
consensus sequence in the promoters of various genes,
including the Ie exon. It has been shown that targeted
disruption of the p50 subunit of NF-k B in mice results in a
substantial decrease in germline Ce transcription in splenic
B cells activated by appropriate stimulation.44 Phosphory-
lation of Ik B is inducible by at least the z isoform of protein
kinase C (PKCz ), which is activated by the lipid products of
phosphatidylinositol (PI) 3-kinase (PI3-K), such as PI 3,4,
5-triphosphate. Activation of PI3-K may be mediated
through the tyrosine phosphorylation of docking proteins,
such as insulin receptor substrate (IRS)-1, IRS-2 and the
c-fes proto-oncogene product (FES).45,46 Previous work
has shown that PI3-K inhibitors, such as wortmannin and
LY294002, inhibit IL-4-induced nuclear expression of
NF-k B by abrogating the translocation of PKCz from
the cytosol to the membrane fraction in a B cell line.47,48
Dominant-negative PKCz also decreases the activation of
the Ie promoter by IL-4. In addition, N-acetyl-L-cysteine
(NAC), a NF-k B inhibitor, partly inhibits IL-4-induced
germline Ce transcription. Transfection of the two decoy
oligodeoxynucleotides containing NF-k B and STAT6 bind-
ing sites into a B cell line results in almost complete
abrogation of IL-4-driven germline Ce transcription.41
These data suggest that a coordinated action of NF-k B
and STAT6 may be required for sufficient induction of
germline Ce transcripts by IL-4. This suggestion is sup-
ported by a recent study indicating that STAT6 and NF-k B
cooperatively bind their cognate DNA binding sites and
synergistically activate transcription.49 Interleukin-4 also
induces the generation of 1,2-diacylglycerol (DAG) without
the initial accumulation of inositol 1,4,5-triphosphate,
through the activation of PI-specific phospholipase C
(PLC)-g l associated with tyrosine-phosphorylated Shc,
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thereby resulting in translocation of PKCd (K Ikizawa and
Y Yanagihara, unpubl. obs., 1998). It should be noted
that PKCd is dependent on DAG, while PKCz is dependent
on PI3-K products and that neither isoform requires Ca2+
for activation. However, the precise roles of PKCd and its
substrate in regulating germline Ce transcription are not
known. In contrast with FES, Shc, IRS-1 and IRS-2 share a
novel phosphotyrosine-binding domain capable of bind-
ing to the phosphorylated NPXY motifs that are present in
the IL-4Ra as well as in the insulin receptor. Thus, Shc also
functions as an adaptor molecule in IL-4 signaling.
The receptor chain IL-4Ra is a crucial component,
required for IL-4 binding, signal transduction and kinase
binding, leading to the cellular responses. An extracellular
variant of human IL-4Ra , containing a valine (Val) for
isoleucine (Ile) substitution at amino acid 50 (numbering
for mature peptide), has recently been shown to associate
with atopic asthma.50 Indeed, a high frequency of Ile50
homozygotes was observed in the atopic asthma group,
compared with the normal and non-atopic groups. In
B cell lines transfected with complete cDNA for the Ile50
and Val50 variants, greater activation of STAT6 and the Ie
promoter was induced in Ile50-transfected cells than in
Val50-transfected cells after IL-4 stimulation.50 However,
the two variants did not alter the ligand-binding affinity 
of IL-4Ra , indicating that the Ile50 variant of IL-4Ra
up-regulates the receptor response to IL-4. In addition to
the Ile50Val substitution, a cytoplasmic variant of IL-4Ra ,
containing an arginine (Arg) 576 to glutamine (Gln)
substitution, has been described in patients with hyper-IgE
syndrome and atopic dermatitis.51 This mutation also
enhances the IL-4 signaling that leads to CD23 expres-
sion. Although activation of STAT6 by IL-4 is not up-
regulated in the presence of the Arg576Gln substitution,
decreased binding of the SH2-containing tyrosine phos-
phatase 1 to the tyrosine-phosphorylated IL-4Ra can be
detected in the mutation. This may lead to exaggerated
IL-4 signaling. These findings demonstrate that both extra-
cellular and cytoplasmic variants of IL-4Ra are associated
with enhanced responsiveness to IL-4.
CD40-MEDIATED SIGNAL TRANSDUCTION
EVENTS LEADING TO DELETIONAL SWITCH
RECOMBINATION
CD40, a member of the TNF receptor superfamily, plays
a key role in T cell-dependent B cell responses.52 CD40
signaling, which is initiated by the binding of CD40 to
CD40L, a non-covalent trimer, activates multiple path-
ways to produce B cell maturation. Despite the absence
of characteristic PTK sequences within the cytoplasmic
domain of CD40, antibody ligation of CD40 on B cells
has been shown to induce tyrosine phosphorylation and
activation of Lyn and, to a lesser extent, Fyn, which are
coupled with increased activity of PI3-K and tyrosine
phosphorylation of PLC-g 2.53,54 Thus, members of the Src
family are involved in CD40 signaling. In addition, the
cytoplasmic region of CD40 is associated with four
members of the TNF receptor-associated factor (TRAF)
family, TRAF2, TRAF3, TRAF5 and TRAF6,55–58 and with
JAK3.59 Although the TRAF proteins have no enzymatic
activity, they function as second messengers in CD40
signaling. Engagement of CD40 also induces activation
of NF-k B and members of the mitogen-activated protein
kinase (MAPK) subfamily.56,57,60 Nuclear factor-k B acti-
vation is mediated by the PI3-K pathway and by TRAF2,
TRAF5 and TRAF6. Furthermore, TRAF2 activates c-Jun
NH2-terminal kinase (JNK) and NF-k B-inducing kinase
(NIK) and TRAF6 activates extracellular signal-regulated
kinase (ERK). Expression of c-Jun is up-regulated by
JNK, whereas ERK induces serine/threonine phosphory-
lation of Elk-1.60 However, the downstream events in the
TRAF3-dependent signaling pathway are not known.
Activated JAK3 induces tyrosine phosphorylation of
STAT3, which leads to complex assembly, nuclear trans-
location and STAT3-dependent gene transcription.59
These data demonstrate that multiple CD40 signaling
pathways are integrated at the level of transcriptional
activation to regulate B cell responses.
The Ie promoter contains a CD40 response element
that is distinct from the IL-4 response element.61 The CD40
response element has binding sites for NF-k B-related
factor and activator protein-1. Nuclear factor-k B inhibi-
tors, such as NAC, have been shown to be effective in
inhibiting CD40-mediated enhancement of IL-4-driven
germline Ce transcription in a B cell line.48 Thus, NF-k B
induced by CD40 ligation may play a role in up-regulating
IL-4-driven germline Ce transcription. In contrast, NAC has
also been shown to inhibit mature Ce transcription and IgE
synthesis in normal B cells costimulated with IL-4 and anti-
CD40 mAb.62 Because mature Ce transcription results
from IgE isotype switching, we examined whether NAC
could influence CD40-mediated switch recombination. As
expected, NAC could inhibit the generation of S m /Se switch
fragments in normal B cells costimulated with IL-4 and anti-
CD40 mAb.41 This result suggests that NF-k B-dependent
steps may be important in activating the switch recombi-
nation machinery, as well as activating expression from the
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Ie promoter. Although the two signal transduction pathways
for IL-4 and CD40 ligation operating through NF-k B inter-
act at the transcriptional level, NF-k B activation triggered
either by IL-4 or by CD40 ligation fails to cause isotype
switching to IgE. This implies that NF-k B activated via the
PI3-K pathway, which is commonly transduced through
IL-4Ra and CD40, does not participate in IgE isotype
switching. Therefore, it is likely that NF-k B activation trig-
gered by TRAF multimerization may contribute, at least in
part, to switch recombination. However, the details of mem-
bers of the TRAF and NF-k B/Rel families that play a role in
regulating the switch machinery are, at present, unknown.
In addition to NF-k B, other DNA-binding  proteins, such as
Ku70/86, which is capable of forming complexes with the
DNA-dependent protein kinase (DNA-PK), and rad51/54,
expressed via switch recombination, are involved in isotype
switching.63–66 Thus, DNA-PK also functions as part of the
switch recombinase. These findings suggest that locali-
zation of DNA-binding proteins may be critically important
in prompting switch recombination.
CONCLUDING REMARKS
Recent advances in elucidating the signaling pathways to
produce B cell maturation have led to new insights into
the molecular mechanisms underlying human IgE syn-
thesis. Terminal differentiation of a single B cell into an
IgE-secreting plasma cell is regulated at the level of tran-
scriptional activation by multiple pathways of B cell
triggering (Fig. 3). Although a combination of signals
delivered by IL-4Ra and CD40 regulate isotype switching
to IgE, the detailed mechanisms of DNA switch recom-
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Fig. 3 B cell transduction
events leading to IgE isotype
switching. Interleukin (IL)-4 acti-
vates STAT6 and nuclear factor
(NF)-k B, which interact at the
level of the Ie promoter, thereby
resulting in sufficient induction of
germline Ce transcription. CD40
ligation, in conjunction with IL-4
stimulation, induces deletional
switch recombination that leads
to IgE switching and mature Ce
transcription. Multiple pathways,
including protein tyrosine kinase
(PTK), tumor necrosis factor
receptor-associated factor (TRAF)
proteins and members of the
mitogen-activated protein kinase
subfamily, are involved in CD40
signaling. DNA-binding proteins,
such as NF-k B, Ku70/86, 
DNA-dependent protein kinase
(DNA-PK) and rad51/54, are
also implicated in switch recom-
bination. However, the detailed
mechanisms of Sm /Se switch 
recombination are presently
unclear. IL-4R, IL-4 receptor; JAK,
Janus kinase; PLC, phospholi-
pase C; DAG, diacylglycerol;
PKC, protein kinase C; STAT,
signal transducers and activators
of transcription; FES, c-fes proto-





bination are, at present, unknown. Identification and
characterization of the key molecules essential for IgE
isotype switching will provide important strategies for the
manipulation of the IgE response in atopic patients.
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